The us company Pfizer and German BioNTech received an order from the United States government in the amount of $ 1.95 billion for the supply of the first batch of a vaccine against coronavirus – a hundred million doses. It promises to make the end of 2020. This is stated in a press release on the website of the German company. It is reported that "American people" will receive the experimental vaccine free of charge.
In BioNTech not exclude that in the future US authorities can purchase of 500 million doses in addition. All in all, a biopharmaceutical company plans to produce before the end of next year, some 1.3 billion doses. It is noteworthy that the agreement about which has been declared today officially lies not only with the Ministry, but the Ministry of defense of the United States. It operates within the framework of the programme for the beginning of deliveries in the US, 300 million doses of medicine for 2021.
At first, Pfizer will have to obtain permission for his "emergency use" from the control of the food and drug administration. Yes, and the drug is not yet registered. CEO of Pfizer albert Burla acknowledged that the company has decided on the clinical trials of a drug "at your own risk, to be able to put it into circulation as soon as possible if it will be OK". It is clarified that the company gets the money only if the vaccine trials are successful, the drug will enter the market.
The development of a vaccine BNT162 based on technology patented by the company BioNTech, and is supported by their partners from Pfizer. "currently she is not allowed to spread anywhere in the world" – said in a release.
